Cargando…

‘Long-COVID’ - a neuroinflammatory disease

Detalles Bibliográficos
Autores principales:	Schou, Thor, Wegener, Gregers, Joca, Sâmia, Bay-Richter, Cecilie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678074/ http://dx.doi.org/10.1016/j.bbi.2022.07.096

Ejemplares similares

Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review
por: Schou, Thor Mertz, et al.
Publicado: (2021)

Antidepressant Effects of NSAIDs in Rodent Models of Depression—A Systematic Review
por: Bay-Richter, Cecilie, et al.
Publicado: (2022)

PS133. The role of Toxoplasma gondii in depression and anxiety - gene-environment interactions in the FSL rat model
por: Bay-Richter, Cecilie, et al.
Publicado: (2016)

PS142. Ketamine is effective in an animal model of treatment resistant depression
por: Pereira, Vitor Silva, et al.
Publicado: (2016)

Maternal stress and placental function; ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin
por: Mathiesen, Line, et al.
Publicado: (2020)

PS137. Evidence that Cannabidiol Induces Acute Antidepressant-Like Efects in Different Animal Models
por: Joca, Samia, et al.
Publicado: (2016)

P2X7 Receptor Signaling in Stress and Depression
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

Sex and Estrous Cycle Are Not Mediators of S-Ketamine’s Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression
por: Arjmand, Shokouh, et al.
Publicado: (2023)

Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
por: Silote, Gabriela P., et al.
Publicado: (2021)

Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases
por: Levin, Seth N., et al.
Publicado: (2021)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019)

Glia Crosstalk in Neuroinflammatory Diseases
por: Bernaus, Ada, et al.
Publicado: (2020)

Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
por: Lima, Isabel Vieira de Assis, et al.
Publicado: (2012)

Glutamate Receptors in Neuroinflammatory Demyelinating Disease
por: Bolton, Christopher, et al.
Publicado: (2006)

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2022)

Editorial: Neuroinflammatory diseases of domestic animals
por: Rossmeisl, John H., et al.
Publicado: (2022)

Editorial: Neurovascular changes in neuroinflammatory diseases
por: Cao, Weidong, et al.
Publicado: (2022)

The Role of Epigenetics in Neuroinflammatory-Driven Diseases
por: Giallongo, Sebastiano, et al.
Publicado: (2022)

Neuroinflammatory paradigms in lysosomal storage diseases
por: Bosch, Megan E., et al.
Publicado: (2015)

Kynurenine pathway metabolism and neuroinflammatory disease
por: Braidy, Nady, et al.
Publicado: (2017)

Autoimmune Neuroinflammatory Diseases: Role of Interleukins
por: Khan, Abdul Waheed, et al.
Publicado: (2023)

Upregulation of Neuroinflammatory Protein Biomarkers in Acute Rhegmatogenous Retinal Detachments
por: Prasad, Minali, et al.
Publicado: (2022)

Mitochondrial Dynamics in Cancer and Neurodegenerative and Neuroinflammatory Diseases
por: Corrado, Mauro, et al.
Publicado: (2012)

Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
por: Molero-Luis, Marta, et al.
Publicado: (2020)

Early detection of thrombin activity in neuroinflammatory disease
por: Davalos, Dimitrios, et al.
Publicado: (2014)

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases
por: Reale, Marcella, et al.
Publicado: (2021)

Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic
por: Levit, Elle, et al.
Publicado: (2022)

Cannabinoid Modulation of Neuroinflammatory Disorders
por: Saito, Viviane M, et al.
Publicado: (2012)

Neuroinflammatory and Demyelinating Disorders of Childhood
por: Nouri, Maryam Nabavi, et al.
Publicado: (2020)

Nitric Oxide Synthase Inhibitors as Antidepressants
por: Wegener, Gregers, et al.
Publicado: (2010)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
por: Dorst, Johannes, et al.
Publicado: (2020)

Marine-derived protein kinase inhibitors for neuroinflammatory diseases
por: Ning, Chong, et al.
Publicado: (2018)

MIP-3β/CCL19 is associated with the intrathecal invasion of mononuclear cells in neuroinflammatory and non-neuroinflammatory CNS diseases in dogs
por: Bartels, Janina, et al.
Publicado: (2014)

Modelling neuroinflammatory phenotypes in vivo
por: Buckwalter, Marion S, et al.
Publicado: (2004)

Neuroinflammatory responses in diabetic retinopathy
por: Yu, Ying, et al.
Publicado: (2015)

The Neuroinflammatory Role of Pericytes in Epilepsy
por: Yamanaka, Gaku, et al.
Publicado: (2021)

Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
por: Rauf, Abdur, et al.
Publicado: (2022)

Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases
por: Jiang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jg9bh2tudmra8hhom5ao8ghsai